Cargando…
CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
OBJECTIVE: Colorectal cancer (CRC) is considered to be the most prevalent malignant tumors that contribute to high cancer-related mortality. However, the signaling pathways involved in CRC and CRC-driven genes are largely unknown. We seek to discover a novel biomarker in CRC. MATERIALS AND METHODS:...
Autores principales: | Gan, Yaqi, Li, Yimin, Li, Tong, Shu, Guang, Yin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217169/ https://www.ncbi.nlm.nih.gov/pubmed/30464611 http://dx.doi.org/10.2147/CMAR.S176833 |
Ejemplares similares
-
Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021) -
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer
por: Liu, Jiaxin, et al.
Publicado: (2022) -
EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer
por: Li, Yimin, et al.
Publicado: (2020) -
CCNA
por: Valentine, Michael, et al.
Publicado: (2008) -
CCNA voice
por: Bateman, David, et al.
Publicado: (2009)